MetLife, Inc.
MET
$69.22
$1.251.84%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.49B | 17.32B | 17.57B | 17.60B | 18.95B |
| Total Other Revenue | 328.00M | 43.00M | -236.00M | 972.00M | -280.00M |
| Total Revenue | 23.81B | 17.36B | 17.34B | 18.57B | 18.67B |
| Cost of Revenue | 19.28B | 12.91B | 13.32B | 13.57B | 14.69B |
| Gross Profit | 4.53B | 4.46B | 4.02B | 5.00B | 3.97B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.42B | 3.24B | 3.05B | 3.09B | 3.10B |
| Total Operating Expenses | 22.70B | 16.14B | 16.37B | 16.66B | 17.79B |
| Operating Income | 1.11B | 1.22B | 969.00M | 1.91B | 875.00M |
| Income Before Tax | 1.12B | 1.21B | 980.00M | 1.35B | 1.38B |
| Income Tax Expenses | 301.00M | 308.00M | 245.00M | 404.00M | 106.00M |
| Earnings from Continuing Operations | 816.00M | 902.00M | 735.00M | 950.00M | 1.28B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.00M | -6.00M | -6.00M | -5.00M | -4.00M |
| Net Income | 809.00M | 896.00M | 729.00M | 945.00M | 1.27B |
| EBIT | 1.11B | 1.22B | 969.00M | 1.91B | 875.00M |
| EBITDA | 1.78B | 1.25B | 997.00M | 1.94B | 1.50B |
| EPS Basic | 1.18 | 1.23 | 1.04 | 1.29 | 1.79 |
| Normalized Basic EPS | 1.05 | 1.13 | 0.90 | 1.23 | 1.24 |
| EPS Diluted | 1.17 | 1.22 | 1.04 | 1.28 | 1.78 |
| Normalized Diluted EPS | 1.04 | 1.12 | 0.90 | 1.22 | 1.23 |
| Average Basic Shares Outstanding | 658.10M | 664.70M | 670.80M | 682.30M | 693.00M |
| Average Diluted Shares Outstanding | 662.20M | 669.10M | 675.00M | 687.00M | 697.90M |
| Dividend Per Share | 0.57 | 0.57 | 0.57 | 0.55 | 0.55 |
| Payout Ratio | 50.19% | 49.55% | 56.65% | 46.56% | 32.26% |